Table 1.

Demographic and laboratory data

	Number of subjects	Sex (F/M):	Age (years):	AST (nv<50IU/1)	GGT (nv<55IU/1)	Bilirubin (nv<20μmo1/1)	IgG (nv 6.5–17g/1)	Autoantibody Titer*
								ANA	SMA	LKM-1
AILD	38	17/21	0.1–34.1 (15.2)
Active patients†	12	5/7	3.6–30.2 (14.6)	55–2462 (100)	143 (27–883)	12–257 (31)	8.5–44.3 (19.1)	0–160 (20)	0–1280 (10)	neg
Remission patients	26	12/14	0.1–34.1 (15.6)	11–49 (23)¶	7–223 (17.5)∞	3–26 (9)§	6.4–29.9 (12.6)‡	0–20 (0)	0–80 (0)	neg

Data presented as range (median) unless noted otherwise; nv: normal value

AILD: autoimmune liver disease

^†: including five patients at disease presentation

AST: aspartate aminotransferase

GGT: gamma glutamyl transferase

IgG: immunoglobulin G

^*: Autoantibody titer shown as reciprocal

ANA: anti-nuclear antibody

SMA: smooth muscle antibody

LKM-1: liver kidney microsomal antibody type 1

^¶P=0.006,

^∞P=0.009,

^§P<0.001,

^‡P=0.01 when comparing AST, GGT, bilirubin and IgG levels between patients with active disease and at remission